Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-03

Clinical Trial Update: Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes [NA]

View source ↗

Summary

The clinical trial investigating isoleucine intake and intermediary metabolism in Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Texas A&M University | Conditions: Type 2 Diabetes | NA | Status: COMPLETED